Compare · CELZ vs MCO
CELZ vs MCO
Side-by-side comparison of Creative Medical Technology Holdings Inc. (CELZ) and Moody's Corporation (MCO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELZ and MCO operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- MCO is the larger of the two at $82.37B, about 21440.5x CELZ ($3.8M).
- Over the past year, CELZ is down 71.5% and MCO is down 8.2% - MCO leads by 63.3 points.
- MCO has been more active in the news (10 items in the past 4 weeks vs 7 for CELZ).
- MCO has more recent analyst coverage (25 ratings vs 1 for CELZ).
- Company
- Creative Medical Technology Holdings Inc.
- Moody's Corporation
- Price
- $0.81-0.47%
- $471.51-0.12%
- Market cap
- $3.8M
- $82.37B
- 1M return
- -59.90%
- +4.77%
- 1Y return
- -71.48%
- -8.17%
- Industry
- Finance: Consumer Services
- Finance: Consumer Services
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 7
- 10
- Recent ratings
- 1
- 25
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Moody's Corporation
Moody's Corporation operates as an integrated risk assessment firm worldwide. It operates in two segments, Moody's Investors Service and Moody's Analytics. The Moody's Investors Service segment publishes credit ratings and provides assessment services on various debt obligations, programs and facilities, and entities that issue such obligations, such as various corporate, financial institution, and governmental obligations; and structured finance securities. This segment provides ratings in approximately 140 countries. Its ratings are disseminated through press releases to the public through electronic media, including the internet and real-time information systems used by securities traders and investors. This segment has rated approximately 5,000 non-financial corporates; 3,600 financial institutions; 16,000 public finance issuers; 145 sovereigns; 47 supranational institutions; 459 sub-sovereigns; and 1,000 infrastructure and project finance issuers, as well as 9,100 structured finance deals. The Moody's Analytics segment develops a range of products and services that support the risk management activities of institutional participants in financial markets; and offers subscription based research, data, and analytical products comprising credit ratings, credit research, quantitative credit scores and other analytical tools, economic research and forecasts, business intelligence and company information products, commercial real estate data and analytical tools, and on-line and classroom-based training services, as well as credentialing and certification services. It also offers software solutions, as well as related risk management services; and offshore analytical and research services with learning solutions and certification programs. The company was formerly known as Dun and Bradstreet Company and changed its name to Moody's Corporation in September 2000. Moody's Corporation was founded in 1900 and is headquartered in New York, New York.
Latest CELZ
- SEC Form S-3 filed by Creative Medical Technology Holdings Inc.
- SEC Form DEF 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Issues Mid-Year Update
- Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
- SEC Form RW filed by Creative Medical Technology Holdings Inc.
- Amendment: SEC Form S-1/A filed by Creative Medical Technology Holdings Inc.
- SEC Form S-1 filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
Latest MCO
- SEC Form S-8 filed by Moody's Corporation
- SEC Form 10-Q filed by Moody's Corporation
- Moody's Corporation Delivers Exceptional Results For Second Quarter 2026
- Moody's Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Jefferies initiated coverage on Moody's with a new price target
- Date Set For Moody's Earnings Release And Investor Teleconference
- CEO, Moody's Analytics Kosmowski Christina was granted 21,542 shares (SEC Form 4)
- President and CEO Fauber Robert sold $668,204 worth of shares (1,467 units at $455.49) as part of a pre-agreed trading plan and exercised 1,167 shares at a strike of $140.03, decreasing direct ownership by 0.57% to 52,264 units (SEC Form 4)
- SVP - General Counsel Steele Richard G sold $71,512 worth of shares (157 units at $455.49) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 1,828 units (SEC Form 4)
- SEC Form 4 filed by Director Minaya Jose